Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

271.15 +6.22 (+2.35%)
Streaming Delayed Price Updated: 1:49 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
Bio-Rad to Participate at Jefferies Virtual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples... 
Via Benzinga
News headline image
Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript ↗
BIO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Bio-Rad Reports First-Quarter 2021 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
A Preview Of Bio-Rad Laboratories's Earnings ↗
On Thursday, April 29, Bio-Rad Laboratories (NYSE:BIO) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And... 
Via Benzinga
News headline image
Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
News headline image
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.